DNA SEQ Alliance
Curated by SignalGenomic analysis and machine learning to identify early drug resistance and for precision drug therapies.
Overview
DNA-SEQ aims to enable more precisely targeted drug therapies for cancer patients by using high throughput sequencing, 3D crystallography and machine learning to identify early drug resistance and to match their specific mutations to more effective cancer therapies. DNA-SEQ combines innovations in the following areas Genome Sequencing, Precise Genome Analysis, Mapping Mutations to Aberrations in Molecular Structure. The company was involved in the co-development of Gleevec.
Key facts
- Founded
- 2013
- Headquarters
- San Diego, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology